Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'synthesis methamphetamine' OR with Authors including 'synthesis methamphetamine' OR with Abstract including 'synthesis methamphetamine' OR with Keywords including 'synthesis methamphetamine'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Fuller RW, Hines CW, Mill... Lowering of Brain Serotonin Levels by Chloramphetamines Biochem Pharmacol 1965
Barfknecht CF, Nichols DE Potential psychotomimetics, Bromomethoxyamphetamines J Med Chem 1971
Barfknecht CF, Nichols DE Potential psychotomimetics. Bromomethoxyamphetamines J Med Chem 1971
Sreenivasan VR Problems in Identification of Methylenediony and Methoxy Amphetamines Journal of Criminal ... 1972
Schmidt CJ, Sonsalla PK, ... Methamphetamine-induced depression of monoamine synthesis in the rat: ... J Neurochem 1985
Stone DM, Merchant KM, Ha... Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... Neuropharmacology 1987
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Scallet AC, Lipe GW, Ali ... Neuropathological evaluation by combined immunohistochemistry and dege... Neurotoxicology 1988
Schmidt CJ, Taylor VL Direct central effects of acute methylenedioxymethamphetamine on serot... Eur J Pharmacol 1988
Fitzgerald RL, Blanke RV,... Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... J Chromatogr 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Schmidt CJ Acute and long-term neurochemical effects of methylenedioxymethampheta... NIDA Res Monogr 1989
Stone DM, Hanson GR, Gibb... In vitro reactivation of rat cortical tryptophan hydroxylase following... J Neurochem 1989
Gibb JW, Stone DM, Johnso... Role of dopamine in the neurotoxicity induced by amphetamines and rela... NIDA Res Monogr 1989
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
Nash JF, Meltzer HY, Gude... Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... J Neurochem 1990
Schmidt CJ, Abbate GM, Bl... Selective 5-hydroxytryptamine2 receptor antagonists protect against th... J Pharmacol Exp Ther 1990
Schmidt CJ, Black CK, Tay... Antagonism of the neurotoxicity due to a single administration of meth... Eur J Pharmacol 1990
Schmidt CJ, Kehne JH Neurotoxicity of MDMA: neurochemical effects Ann N Y Acad Sci 1990
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Pan HS, Wang RY The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... Brain Res 1991
Schechter MD Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... Gen Pharmacol 1991
Schmidt CJ, Taylor VL, Ab... 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... J Pharmacol Exp Ther 1991
Schmidt CJ, Black CK, Tay... The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... Eur J Pharmacol 1992
Schmidt CJ, Fadayel GM, S... 5-HT2 receptors exert a state-dependent regulation of dopaminergic fun... Eur J Pharmacol 1992
Zhao ZY, Castagnoli N Jr,... Synthesis and neurotoxicological evaluation of putative metabolites of... Chem Res Toxicol 1992
Bohn M, Bohn G, Blaschke ... Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... Int J Legal Med 1993
Huang X, Nichols DE 5-HT2 receptor-mediated potentiation of dopamine synthesis and central... Eur J Pharmacol 1993
Shiue CY, Shiue GG, Rysav... Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... Nucl Med Biol 1993
Marona-Lewicka D, Nichols... Behavioral effects of the highly selective serotonin releasing agent 5... Eur J Pharmacol 1994
Schmidt CJ, Sullivan CK, ... Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increa... J Neurochem 1994
White SR, Duffy P, Kaliva... Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... Neuroscience 1994
Green AR, Cross AJ, Goodw... Review of the pharmacology and clinical pharmacology of 3,4-methylened... Psychopharmacology (... 1995
Miller RT, Lau SS, Monks ... Effects of intracerebroventricular administration of 5-(glutathion-S-y... Chem Res Toxicol 1996
Gudelsky GA, Nash JF Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... J Neurochem 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Gifford AN, Minabe Y, Too... Examination of the action of 3,4-methylenedioxymethamphetamine on rat ... Synapse 1996
Geyer MA Serotonergic functions in arousal and motor activity Behav Brain Res 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Muck-Seler D, Takahashi S... The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT syn... Brain Res 1998
Sprague JE, Everman SL, N... An integrated hypothesis for the serotonergic axonal loss induced by 3... Neurotoxicology 1998
Sabol KE, Seiden LS Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... Brain Res 1998
Westwood SC, Hanson GR Effects of stimulants of abuse on extrapyramidal and limbic neuropepti... J Pharmacol Exp Ther 1999
Nishisawa S, Mzengeza S, ... Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin ... Neurochem Int 1999
Schirren CA, Berghaus TM,... Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... Ann Intern Med 1999
Erdtmann-Vourliotis M, Ma... Acute injection of drugs with low addictive potential (delta(9)-tetrah... Brain Res Mol Brain ... 1999
Aalberg L, DeRuiter J, No... Chromatographic and Mass Spectral Methods of Identification for the Si... J Chromatogr Sci 2000
Christophersen AS Amphetamine designer drugs - an overview and epidemiology Toxicol Lett 2000
Kuhn DM, Geddes TJ Molecular footprints of neurotoxic amphetamine action [In Process Cita... Ann N Y Acad Sci 2000
O'Shea E, Easton N, Fry J... Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... J Neurochem 2002
Boot BP, Mechan AO, McCan... MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... Eur J Pharmacol 2002
Lebsanft HB, Mayerhofer A... Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... J Neural Transm 2003
Easton N, Fry J, O'Shea E... Synthesis, in vitro formation, and behavioural effects of glutathione ... Brain Res 2003
Dafters RI, Biello SM The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on seroton... Neurosci Lett 2003
Moyano S, Frechilla D, De... NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... Psychopharmacology (... 2004
Garcia-Osta A, Del Rio J,... Increased CRE-binding activity and tryptophan hydroxylase mRNA express... Brain Res Mol Brain ... 2004
Burchett SA, Hicks TP The mysterious trace amines: protean neuromodulators of synaptic trans... Prog Neurobiol 2006
Freudenmann RW, Oxler F, ... The origin of MDMA (ecstasy) revisited: the true story reconstructed f... Addiction 2006
Capela JP, Macedo C, Bran... Neurotoxicity mechanisms of thioether ecstasy metabolites Neuroscience 2007
Ambrose JB, Bennett HD, L... Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... Neurologist 2010
Heather E, Shimmon R, McD... Organic Impurity Profiling of 3,4-Methylenedioxymethamphetamine ... Forensic Sci Int 2020